Axa’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-560
Closed -$34K 1068
2023
Q3
$34K Hold
560
﹤0.01% 1053
2023
Q2
$36.8K Sell
560
-665
-54% -$43.8K ﹤0.01% 1068
2023
Q1
$77.9K Sell
1,225
-750
-38% -$47.7K ﹤0.01% 1084
2022
Q4
$273K Buy
+1,975
New +$273K ﹤0.01% 1060
2021
Q1
Sell
-16,024
Closed -$8.98M 1219
2020
Q4
$8.98M Buy
16,024
+3,283
+26% +$1.84M 0.03% 549
2020
Q3
$8.9M Buy
12,741
+2,423
+23% +$1.69M 0.03% 492
2020
Q2
$8.16M Buy
+10,318
New +$8.16M 0.03% 484
2018
Q3
Sell
-1,598
Closed -$3.25M 1334
2018
Q2
$3.25M Sell
1,598
-371
-19% -$754K 0.01% 745
2018
Q1
$4.35M Buy
1,969
+47
+2% +$104K 0.02% 690
2017
Q4
$4.44M Buy
1,922
+1,073
+126% +$2.48M 0.02% 686
2017
Q3
$1.51M Sell
849
-3,586
-81% -$6.38M 0.01% 866
2017
Q2
$6.04M Sell
4,435
-5,127
-54% -$6.98M 0.03% 561
2017
Q1
$11.3M Sell
9,562
-562
-6% -$662K 0.05% 386
2016
Q4
$8.09M Sell
10,124
-2,510
-20% -$2.01M 0.04% 462
2016
Q3
$11.1M Buy
12,634
+7
+0.1% +$6.15K 0.05% 370
2016
Q2
$7.08M Buy
12,627
+1,136
+10% +$637K 0.03% 487
2016
Q1
$6.33M Buy
11,491
+1,857
+19% +$1.02M 0.03% 495
2015
Q4
$8.02M Sell
9,634
-690
-7% -$574K 0.04% 444
2015
Q3
$11.4M Buy
10,324
+3,888
+60% +$4.31M 0.05% 351
2015
Q2
$14M Hold
6,436
0.06% 323
2015
Q1
$10.1M Buy
6,436
+1,114
+21% +$1.74M 0.04% 407
2014
Q4
$6.32M Buy
+5,322
New +$6.32M 0.03% 492